Monoaminergic modulation of emotional impact in the inferomedial prefrontal cortex

Synapse

Volumn 63, Issue 2, 2009, Pages 160-166

  Geday, Jacob ^a,b   Gjedde, Albert ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

BA11; Emotional reactivity; Inferomedial prefrontal cortex; Monoamines; Visual stimuli

Indexed keywords

MONOAMINE; NORADRENALIN UPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; BRAIN BLOOD FLOW; EMOTION; FEMALE; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; MALE; MONOAMINE NERVE CELL; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; RATING SCALE; REGRESSION ANALYSIS; STIMULUS RESPONSE; VOLUNTEER;

BIOGENIC MONOAMINES; BRAIN MAPPING; CEREBROVASCULAR CIRCULATION; CLOMIPRAMINE; EMOTIONS; FEMALE; HUMANS; MALE; POSITRON-EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; SEROTONIN UPTAKE INHIBITORS;

EID: 59949094100     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20570     Document Type: Article

References (41)

1. Adams KH, Pinborg LH, Svarer C, Hasselbalch SG, Holm S, Haug- bøl S, Madsen K, Frøkjaer V, Martiny L, Paulson OB, Knudsen GM. 2004. A database of [(18)F]-altanserin binding to 5-HT(2A) receptors in normal volunteers: normative data and relationship to physiological and demographic variables. Neuroimage 21:1105-1113.
2. Amodio DM, Frith CD. 2006. Meeting of minds: the medial frontal cortex and social cognition. Nat Rev Neurosci 7:268-277.
3. Bailer UF, Frank GK, Henry SE, Price JC, Meltzer CC, Weissfeld L, Mathis CA, Drevets WC, Wagner A, Hoge J, Ziolko SK, McConaha CW, Kaye WH. 2005. Altered brain serotonin 5-HT1A receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [carbonyl11C]WAY-100635. Arch Gen Psychiatry 62:1032-1041.
4. Bailer UF, Frank GK, Henry SE, Price JC, Meltzer CC, Mathis CA, Wagner A, Thornton L, Hoge J, Ziolko SK, Becker CR, McConaha
5. CW, Kaye WH. 2007. Exaggerated 5-HT1A but normal 5-HT2A receptor activity in individuals ill with anorexia nervosa. Biol Psychiatry 61:1090-1099.
6. Bech P. 1988. Rating scales for mood disorders: applicability, consistency and construct validity. Acta Psychiatr Scand 78(Suppl 345):45-55.
7. Bech P, Kastrup M, Rafaelsen OJ. 1986. Mini-compendium of rating scales for states of anxiety, depression, mania, schizophrenia with corresponding DSM-III syndromes. Acta Psychiatr Scand 73 (Suppl. 326):6-37.
8. Bhagwagar Z, Hinz R, Taylor M, Fancy S, Cowen P, Grasby P. 2006. Increased 5-HT2A receptor binding in euthymic. medication-free patients recovered from depression: A positron emission study with [11C]MDL 100,907. Am J Psychiatry 163:1580-1587.
9. Borg J, Andrée B, Soderstrom H, Farde L. 2003. The serotonin system and spiritual experiences. Am J Psychiatry 160:1965-1969.
10. Damasio AR. 1994. Descartes' error: Emotion, reason, and the human brain. New York: Putnam.
11. Duman RS. 2004. The neurochemistry of depressive disorders: Preclinical studies, in neurobiology of mental illness. In: Charney D, Nestler EJ, editors. New York: Oxford University Press. p 421-439
12. Folstein MF, Folstein SE, McHugh PR. 1975. 'Minimental state'-A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198.
13. Geday J, Hermansen F, Rosenberg R, Smith DF. 2005. Serotonin modulation of cerebral blood flow measured with positron emission tomography (PET) in humans. Synapse 55:224-229.
14. Geday J, Ostergaard K, Gjedde A. 2006. Stimulation of subthalamic nucleus inhibits emotional activation of fusiform gyrus. Neuroimage 33:706-714.
15. Geday J, Kupers R, Gjedde A. 2007. As time goes by: Temporal constraints on emotional activation of inferior medial prefrontal cortex. Cereb Cortex 17:2753-2759.
16. Graff-Guerrero A, De la Fuente-Sandoval C, Camarena B, Gomez- Martin D, Apiquia R, Fresa A, Aguilar A, Mendez-Nunez JC, Escalona-Huerta C, Drucker-Coli R, Nicolinie H. 2005. Frontal and limbic metabolic differences in subjects selected according to genetic variation of the SLC6A4 gene polymorphism. Neuroimage 25:1197-1204.
17. Greenberg BD, Li Q, Lucas FR, Hu S, Sirota LA, Benjamin J, Lesch KP, Hamer D, Murphy DL. 2000. Association between the serotonin transporter promoter polymorphism and personality traits in a primarily female population sample. Am J Med Genet 96:202-216.
18. Grosbras MH, Paus T. 2006. Brain networks involved in viewing angry hands or faces. Cereb Cortex 16:1087-1096.
19. Harvey PO, Fossati P, Lepage M. 2007a. Modulation of memory formation by stimulus content: Specific role of the medial prefrontal cortex in the successful encoding of social pictures. Cogn Neurosci 19:351-362.
20. Harvey PO, Pruessner J, Czechowska Y, Lepage M. 2007b. Individual differences in trait anhedonia: A structural and functional magnetic resonance imaging study in non-clinical subjects. Mol Psychiatry 12:703, 767-775.
21. Iidaka T, Omori M, Murata T, Kosaka H, Yonekura Y, Okada T, Sadato N. 2001. Neural interaction of the amygdala with the prefrontal and temporal cortices in the processing of facial expressions as revealed by fMRI. J Cogn Neurosci 13:1035-1047.
22. Lang PJ, Bradley MM, Cuthbert BN. 2005. International affective picture system (IAPS): Affective ratings of pictures and instruction manual. Technical Report A-6. University of Florida, Gainesville, FL.
23. Lesch KP, Mossner R. 1998. Genetically driven variation in serotonin uptake: Is there a link to affective spectrum, neurodevelopmental, and neurodegenerative disorders? Biol Psychiatry 44:179-192.
24. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL. 1996. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274:1527-1531.
25. 2a adrenergic receptor gene polymorphism and adolescent personality. Am J Med Genet B Neuropsychiatr Genet. Am J Med Genet B Neuropsychiatr Genet 147B:418-423.
26. Moresco FM, Dieci M, Vita A, Messa C, Gobbo C, Galli L, Rizzo G, Panzacchi A, De Peri L, Invernizzi G, Fazio F. 2002. In Vivo serotonin 5HT2A receptor binding and personality traits in healthy subjects: A positron emission tomography study. NeuroImage 17:1470-1478.
27. Møller M, Jakobsen S, Gjedde A. 2007. Parametric and regional maps of free serotonin 5HT1A receptor sites in human brain as function of age in healthy humans. Neuropsychopharmacology. 32:1707-1714.
28. Neumeister A, Drevets WC, Belfer I, Luckenbaugh DA, Henry S, Bonne O, Herscovitch P, Goldman D, Charney DS. 2006. Effects of a alpha 2C-adrenoreceptor gene polymorphism on neural responses to facial expressions in depression. Neuropsychopharmacology 31:1750-1756.
29. Ochsner KN, Gross JJ. 2005. The cognitive control of emotion. Trends Cogn Sci 9:242-249.
30. Oquendo MA, Krunic A, Parsey RV, Milak M, Malone KM, Anderson A, van Heertum RL, John Mann J. 2005. Positron emission tomography of regional brain metabolic responses to a serotonergic challenge in major depressive disorder with and without borderline personality disorder. Neuropsychopharmacology 30:1163-1172.
31. Paradiso S, Johnson DL, Andreasen NC, O'Leary DS, Watkins GL, Ponto LL, Hichwa RD. 1999. Cerebral blood flow changes associated with attribution of emotional valence to pleasant, unpleasant, and neutral visual stimuli in a PET study of normal subjects. Am J Psychiatry 156:1618-1629.
32. Peroutka SJ, Snyder SH. 1983. Multiple serotonin receptors and their physiological significance. Fed Proc 42:213-217.
33. Phan KL, Wager T, Taylor SF, Liberzon J. 2002. Functional neuroanatomy of emotion: A meta-analysis of emotion activation studies in PET and fMRI. Neuroimage 16:331-348.
34. Phillips ML, Bullmore ET, Howard R, Woodruff PW, Wright IC, Williams SC, Simmons A, Andrew C, Brammer M, David AS. 1998. Investigation of facial recognition memory and happy and sad facial expression perception: an fMRI study. Psychiatry Res 83:127-138.
35. Raichle ME, MacLeod AM, Snyder AZ, Powers WJ, Gusnard DA, Shulman GL. 2001. A default mode of brain function. Proc Natl Acad Sci USA 98:676-682.
36. Ramos BP, Arnsten AF. 2007. Adrenergic pharmacology and cognition: focus on the prefrontal cortex. Pharmacol Ther 113:523-536.
37. Schilbach L, Wohlschlaeger AM, Kraemer NC, Newen A, Shah NJ, Fink GR, Vogeley K. 2006. Being with virtual others: Neural correlates of social interaction. Neuropsychologia 44:718-730.
38. Smith DF, Geday J. 2001. PET neuroimaging of clomipramine challenge in humans: Focus on the thalamus. Brain Res 892:193-197.
39. Soloff PH, Meltzer CC, Greer PJ, Constantine D, Kelly TM. 2000. A fenfluramine-activated FDG-PET study of borderline personality disorder. Biol Psychiatry 47:540-547.
40. Talairach J, Tournoux P. 1988. A Co-planar stereotaxic atlas of the human brain. Stuttgart: Thieme.
41. Worsley KJ, Marrett S, Neelin P, Vandal AC, Friston KJ, Evans AC. 1996. A unified statistical approach for determining significant signals in images of cerebral activation. Hum Brain Mapp 4:458-473.